COMPANY
ChemDiv
Service / Tools company
- Type
- CRO
- Services
- Chemistry / medicinal chemistry, In vivo pharmacology, Toxicology / safety, Chemistry / synthesis
- Serves
- Small molecules
Contact Opens the company's own website
NIH awards 8
- NIH award 5P41GM079583-03 FY2008: $61,640 awarded for that fiscal year; activity P41 (OTHER_NIH); PI PARKER, MATTHEW A; recipient as written: CHEMDIV, INC., SAN DIEGO, CA. EXPLORATION OF NEW REGIONS OF DIVERSITY SPAC source ↗
- NIH award 5P41GM079583-02 FY2007: $239,234 awarded for that fiscal year; activity P41 (OTHER_NIH); PI PARKER, MATTHEW A; recipient as written: CHEMDIV, INC., SAN DIEGO, CA. EXPLORATION OF NEW REGIONS OF DIVERSITY SPA source ↗
- NIH award 5R42DK068913-03 FY2007: $373,418 awarded for that fiscal year; activity R42 (STTR); PI OKUN, ILYA; recipient as written: CHEMDIV, INC., SAN DIEGO, CA. Identification of Novel ACTH Small Molecule Antagonists source ↗
- NIH award 1R43DK076334-01A1 FY2007: $100,000 awarded for that fiscal year; activity R43 (SBIR); PI OKUN, ILYA; recipient as written: CHEMDIV, INC., SAN DIEGO, CA. Discovery of Small Molecule hACC2 Inhibitors for Trea source ↗
- NIH award 1P41GM079583-01 FY2006: $208,365 awarded for that fiscal year; activity P41 (OTHER_NIH); PI PARKER, MATTHEW A; recipient as written: CHEMDIV, INC., SAN DIEGO, CA. NEW REGIONS OF DIVERSITY SPACE IN ERGOT-BAS source ↗
- NIH award 2R42DK068913-02A1 FY2006: $376,668 awarded for that fiscal year; activity R42 (STTR); PI OKUN, ILYA; recipient as written: CHEMDIV, INC., SAN DIEGO, CA. Identification of Novel ACTH Small Molecule Antagonis source ↗
- NIH award 1R41DK068913-01 FY2004: $100,000 awarded for that fiscal year; activity R41 (STTR); PI OKUN, ILYA; recipient as written: CHEMDIV, INC., SAN DIEGO, CA. Identification of Novel ACTH small molecule Antagonists source ↗
- NIH award 1R41DK067716-01 FY2004: $100,000 awarded for that fiscal year; activity R41 (STTR); PI OKUN, ILYA; recipient as written: CHEMDIV, INC., SAN DIEGO, CA. DRUG DISCOVERY FOR TREATMENT OF OBESITY source ↗